Literature DB >> 35169109

Urgency and Its Association With Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis.

Jared A Sninsky1,2, Edward L Barnes1,2, Xian Zhang1,2, Millie D Long1,2.   

Abstract

INTRODUCTION: Urgency, the immediate need to defecate, is common in active ulcerative colitis (UC). We investigated the association of urgency in patients with UC with (i) quality of life (QoL) domains and (ii) future hospitalizations, corticosteroid use, and colectomy for UC.
METHODS: We conducted a cross-sectional and subsequent longitudinal study within Inflammatory Bowel Disease Partners, a patient-powered research network. We described associations of levels of urgency in patients with UC with Patient-Reported Outcomes Measurement Information System QoL domains. We conducted a longitudinal cohort to determine associations between baseline urgency and subsequent hospitalization, corticosteroid use, or colectomy for UC within 12 months. We used bivariate statistics and logistic regression models to describe independent associations.
RESULTS: A total of 632 patients with UC were included in the cross-sectional study. After adjusting for clinical variables, rectal bleeding, and stool frequency, urgency defined as "hurry," "immediately," and "incontinence" increased the odds of social impairment (odds ratio [OR] 2.05 95% confidence interval [CI] 1.24-3.4, OR 2.76 95% CI 1.1-6.74, and OR 7.7 95% CI 1.66-38.3, respectively) compared with "no hurry." Urgency also significantly increased the odds of depression, anxiety, and fatigue. Urgency was associated with a significant increase in risk of hospitalizations and corticosteroids, whereas "hurry," "immediately," and "incontinence" increased the odds of colectomy within 12 months by 1.42 (1.15-1.75), 1.90 (1.45-2.50), and 3.69 (2.35-5.80). DISCUSSION: We demonstrated that urgency is a patient-reported outcome independently associated with compromised QoL and future risk of hospitalizations, corticosteroids, and colectomy. Our findings support the consideration of urgency as a UC-specific patient-reported outcome and its use as an outcome in clinical trials to capture QoL and risk of clinical decompensation.
Copyright © 2022 by The American College of Gastroenterology.

Entities:  

Mesh:

Year:  2022        PMID: 35169109      PMCID: PMC9064909          DOI: 10.14309/ajg.0000000000001685

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   12.045


  20 in total

1.  Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.

Authors:  Millie D Long; Michael D Kappelman; Christopher F Martin; James D Lewis; Lloyd Mayer; Patricia M Kinneer; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2012-01-27       Impact factor: 5.325

2.  The Development of Patient-Reported Outcome Measures in Inflammatory Bowel Disease.

Authors:  Peter D R Higgins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-11

3.  STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

Authors:  Dan Turner; Amanda Ricciuto; Ayanna Lewis; Ferdinando D'Amico; Jasbir Dhaliwal; Anne M Griffiths; Dominik Bettenworth; William J Sandborn; Bruce E Sands; Walter Reinisch; Jürgen Schölmerich; Willem Bemelman; Silvio Danese; Jean Yves Mary; David Rubin; Jean-Frederic Colombel; Laurent Peyrin-Biroulet; Iris Dotan; Maria T Abreu; Axel Dignass
Journal:  Gastroenterology       Date:  2021-02-19       Impact factor: 22.682

4.  Health-related quality of life in glomerular disease.

Authors:  Pietro A Canetta; Jonathan P Troost; Shannon Mahoney; Amy J Kogon; Noelle Carlozzi; Sharon M Bartosh; Yi Cai; T Keefe Davis; Hilda Fernandez; Alessia Fornoni; Rasheed A Gbadegesin; Emily Herreshoff; John D Mahan; Patrick H Nachman; David T Selewski; Christine B Sethna; Tarak Srivastava; Katherine R Tuttle; Chia-Shi Wang; Ronald J Falk; Ali G Gharavi; Brenda W Gillespie; Larry A Greenbaum; Lawrence B Holzman; Matthias Kretzler; Bruce M Robinson; William E Smoyer; Lisa M Guay-Woodford; Bryce Reeve; Debbie S Gipson
Journal:  Kidney Int       Date:  2019-02-27       Impact factor: 10.612

5.  Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy.

Authors:  Bjørn Rasmussen; Peter Haastrup; Sonja Wehberg; Jens Kjeldsen; Frans Boch Waldorff
Journal:  Scand J Gastroenterol       Date:  2020-05-22       Impact factor: 2.423

6.  An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.

Authors:  Meenakshi Bewtra; Colleen M Brensinger; Vesselin T Tomov; Tram B Hoang; Carly E Sokach; Corey A Siegel; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

7.  A simple clinical colitis activity index.

Authors:  R S Walmsley; R C Ayres; R E Pounder; R N Allan
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

8.  Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial.

Authors:  Mary M McDermott; Bonnie Spring; Jeffrey S Berger; Diane Treat-Jacobson; Michael S Conte; Mark A Creager; Michael H Criqui; Luigi Ferrucci; Heather L Gornik; Jack M Guralnik; Elizabeth A Hahn; Peter Henke; Melina R Kibbe; Debra Kohlman-Trighoff; Lingyu Li; Donald Lloyd-Jones; Walter McCarthy; Tamar S Polonsky; Christopher Skelly; Lu Tian; Lihui Zhao; Dongxue Zhang; W Jack Rejeski
Journal:  JAMA       Date:  2018-04-24       Impact factor: 56.272

9.  Correlation of Patient-Reported Outcome (PRO-2) with Endoscopic and Histological Features in Ulcerative Colitis and Crohn's Disease Patients.

Authors:  Sanja Dragasevic; Aleksandra Sokic-Milutinovic; Milica Stojkovic Lalosevic; Tamara Milovanovic; Srdjan Djuranovic; Ivan Jovanovic; Sanja Rajic; Mirjana Stojkovic; Biljana Milicic; Stefan Kmezic; Branislav Oluic; Marko Aleksic; Aleksandra Pavlovic Markovic; Dragan Popovic
Journal:  Gastroenterol Res Pract       Date:  2020-04-02       Impact factor: 2.260

10.  Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.

Authors:  Subrata Ghosh; Yuri Sanchez Gonzalez; Wen Zhou; Ryan Clark; Wangang Xie; Edouard Louis; Edward V Loftus; Julian Panes; Silvio Danese
Journal:  J Crohns Colitis       Date:  2021-12-18       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.